Associated Press (11.01.05) - Monday, December 05, 2005
Carla K. Johnson

In affluent countries, many women get annual Pap smears, in which cells are scraped from the cervix and examined in a lab. If the test is abnormal, a patient returns for a biopsy. If the biopsy indicates signs of cancer, the woman and her physician discuss treatment options.

But in poor countries, lab testing and biopsies are rare. Poor US women may not get regular Pap exams, or may fail to return for follow-up testing, said Dr. Wendy Brewster, a University of California-Irvine researcher and co-author of one of the studies.

To examine ways to get more poor women tested and treated, Brewster and colleagues studied 3,521 women in largely Hispanic neighborhoods in Orange County, Calif., who underwent Pap smears. One group of the women remained at the clinic to await results. If their test indicated high-grade precancerous lesions, the women underwent a procedure that day to remove a layer of the cervix. Women in the comparison group who had abnormal results were referred for later follow-up care.

At six- and 12-month follow-up, researchers found that women in the single-visit group were considerably more likely to have completed their care than women in the comparison group. Biopsy samples taken before treatment showed that two out of 14 women had the procedure unnecessarily because their biopsies were negative. While the procedure is considered safe, it still carries risks.

"We may have to decide what's feasible, what we can afford and what's the best care for different groups," noted Brewster.

In the second study, funded by the Bill and Melinda Gates Foundation, researchers conducted two different screenings on 6,555 women in South Africa. One test was for human papillomavirus (HPV), a common STD that causes most cervical cancer, and the other was a simple, inexpensive test for precancerous lesions. The women were divided into three groups. In the first group, only those women who tested HPV- positive were given cryotherapy, a procedure that kills cervical cells by freezing them with nitrous oxide. In the second group, only the women who tested positive for precancerous lesions had cryotherapy. Treatment for the third group was six months later.

According to the researchers at Columbia University and the University of Cape Town, the HPV test was more accurate than the cheaper test, but both exams reduced the incidence of precancerous lesions. However, four out of five women in the two groups that received immediate treatment did not have a precancerous condition. Co-author Dr. Thomas C. Wright Jr. of Columbia said the trade-off between benefits and risks was reasonable in order to save lives.

"The important thing is to link testing with treatment," said Dr. Paul Blumenthal of Johns Hopkins University, co-author of an accompanying editorial on the studies. "If you do that without a diagnostic step, as long as treatment is safe, you're well within the bounds of good medicine."

The studies, "Feasibility of Management of High-Grade Cervical Lesions in a Single Visit," and "Screen-and-Treat Approaches for Cervical Cancer Prevention in Low-Resource Settings," and the editorial, "Cervical Cancer Prevention; Making Programs More Appropriate and Pragmatic," were published in the Journal of the American Medical Association (2005;294(17):2182-2187, 2173-2181, and 2225-2228, respectively.)
051205
AD052449

Copyright © 2005 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 2005. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2005. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.